“Roflumilast – a Phosphodiesterase-4 Inhibitor Licensed for Add-on Therapy in Severe COPD”. Swiss Medical Weekly, vol. 142, no. 2930, July 2012, p. w13628, https://doi.org/10.4414/smw.2012.13628.